Back to Authors

Wells, Ali

https://orcid.org/0000-0001-7410-9832

Mayo Clinic

Mayo Clinic in Florida

Citations 2

Internet Use by Gynecologic Oncology Patients and Its Relationship with Anxiety
Corrales, Dalia M, Wells, Ali , Breitkopf, Carmen Radecki , Peña, Gabriela de la, Kaplan, Alan L., King, Lorrie S, Robazetti, Sonia C., Dinh, Tri A., Wells, Ali E, Radecki Breitkopf, Carmen, Corrales, Dalia M

Journal of Health Communication | February 23, 2018 | Volume: 23 | Issue: 3 | Pages: 299-305

10.1080/10810730.2018.1442529 Get It

Trigger Point Injections for Pelvic Floor Myofascial Spasm Refractive to Primary Therapy
Fouad, Lina S., Pettit, Paul D. , Threadcraft, Marcus , Wells, Ali , Micallef, Audrey, Chen, Anita H. , Fouad, Lina

Journal of Endometriosis and Pelvic Pain Disorders | May 7, 2017 | Volume: 9 | Issue: 2 | Pages: 125-130

10.5301/jeppd.5000283 Get It

Introduction A retrospective chart review was conducted of visual analog scale (VAS) scores completed before and after trigger point injections (TPIs) for pelvic floor myofascial spasm to evaluate response. Methods Sixty-eight female patients who underwent TPIs from October 9, 2007 to March 12, 2015 were included. The primary end point was the difference between scores. Secondary analyses were conducted for patients who needed repeat TPIs. Descriptive and paired t test analyses were used. Results The key result was an improvement in VAS scores for 65% (44/68) of patients (p<0.0001). The median pre-injection VAS score was 7 (1 to 10), (mean 6.3). The median post-injection VAS score was 4 (0 to 9), (mean 4.3). The median difference between scores in patients who improved was 3 (1 to 8), (mean 3.6). Seventeen of 68 (25%) patients needed repeat TPI, and the median time between injections was 1.5 months (1 to 7 months), (mean 2.2 months). When analyzing pre-injection VAS scores in patients who underwent subsequent repeat injection when compared to patients who did not require repeat injection, there was no difference (p = 0.32). In addition, the differences between pre- and post-injection VAS scores in the patients who underwent repeat injection and those who did not was not significant (p = 0.26). Conclusions We report on 68 women who underwent TPIs, with an improvement in VAS pain scores in 65%. It appears that TPIs for pelvic floor myofascial spasm are successful in reducing pain scores for patients who are refractory to primary therapy.